Jasper Therapeutics, Inc.JSPRWNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.4%
5Y CAGR+74.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+27.4%/yr
Annual compound
5Y CAGR
+74.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
16.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $76.24M | +10.7% |
| 2023 | $68.86M | +34.5% |
| 2022 | $51.20M | +39.0% |
| 2021 | $36.83M | +78.1% |
| 2020 | $20.68M | +339.1% |
| 2019 | $4.71M | - |